Publications by authors named "Xinyi Choi"
Article Synopsis
- The study aimed to analyze how motor, non-motor, and cognitive abilities progress in early-stage Parkinson's Disease (PD) patients, particularly those with Mild Cognitive Impairment (MCI).
- Researchers assessed 205 PD patients over five years, comparing those with MCI to those with normal cognition, using various scoring methods to evaluate disease progression.
- Results showed that PD-MCI patients experienced faster declines in motor functions and cognitive domains, particularly in visuospatial and perceptual abilities, highlighting the need for tailored management strategies for these patients.
Article Synopsis
- The study investigates data-driven subtypes of Parkinson's disease (PD) among Asian patients, focusing on how motor and non-motor symptoms progress over a 5-year period.
- Using various scales to measure symptom severity and cognitive function, researchers categorized 206 early PD patients into three clusters, with Cluster A (severe subtype) showing the fastest progression across various symptoms.
- The findings highlight the need for tailored intervention strategies for PD patients, especially those in the severe cluster, to manage symptoms such as mood, perceptual issues, and cognitive decline more effectively.
Article Synopsis
- This study investigates various factors linked to mild cognitive impairment (MCI) in Parkinson's disease, using a method called Shapley variable importance cloud (ShapleyVIC) to analyze their significance collectively.
- Out of 41 examined variables, 22 were found to be important, and 8 were selected as key risk factors for PD-MCI, including education level, hypertension history, motor scores, triglyceride levels, and a specific genetic marker (SNCA rs6826785).
- The findings suggest that managing triglyceride and apolipoprotein A1 levels may help prevent cognitive impairment in early Parkinson’s patients, while the genetic marker could serve as a potential target for new treatments.
Article Synopsis
- Diffusion kurtosis imaging (DKI) can assess microstructural changes in brain tissue, potentially aiding in the management of early Parkinson's disease (PD).* -
- A study of 262 participants (185 with PD) found that baseline measurements showed higher mean kurtosis in specific brain regions associated with PD, and this increased further over two years while remaining stable in healthy controls.* -
- Despite these imaging changes indicating abnormal progression in PD, they did not correlate with the decline in motor function for the participants with PD.*
Background: Sleep disorders are common in Parkinson's disease (PD). However, the longitudinal relationship between sleep quality and the other non-motor symptoms of PD has not been well characterized, especially in early PD.
Objective: To explore the value of baseline sleep quality in predicting the progression of other non-motor symptoms in early PD.
Background: Neurofilament light is a marker of axonal degeneration, whose measurement from peripheral blood was recently made possible by new assays.
Objective: We aimed to determine whether plasma neurofilament light chain (NfL) concentration reflects brain white matter integrity in patients with early Parkinson's disease (PD).
Methods: 137 early PD patients and 51 healthy controls were included.
Biomarker characterization of clinical subtypes of Parkinson Disease.
NPJ Parkinsons Dis
August 2022
Article Synopsis
- A study aimed at identifying clinical subtypes of Parkinson Disease (PD) in an Asian cohort, involving 206 patients, explored the relationship between clinical assessments, genetics, and blood markers.
- Using hierarchical clustering, three distinct PD subtypes were identified: cluster A (severe), cluster B (intermediate), and cluster C (mild), which differed in motor and cognitive symptoms as well as genetic markers.
- The severe subtype (cluster A) showed lower frequencies of certain genetic alleles and higher levels of homocysteine and C-reactive protein, suggesting these biomarkers could help in further stratifying PD subtypes and recognizing more severe cases.
Background: Lipid biomarkers have potential neuroprotective effects in Parkinson's disease (PD) and there is limited evidence in the field.
Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and PD.
Methods: A total of 205 PD patients and 102 non-PD subjects were included from Early Parkinson's disease Longitudinal Singapore (PALS) cohort.
The alpha-synuclein gene promoter (SNCA-Rep1) is associated with Parkinson's disease (PD), but its relationship with performance across individual cognitive domains in early PD is unknown. This study aims to investigate Rep1 polymorphism and longitudinal change in cognition in early PD. In this longitudinal study, Rep1 allele lengths ("long" and "short") were determined in 204 early PD patients.
View Article and Find Full Text PDFVarious classifications have been proposed to subtype Parkinson's disease (PD) based on their motor phenotypes. However, the stability of these subtypes has not been properly evaluated. The goal of this study was to understand the distribution of PD motor subtypes, their stability over time, and baseline factors that predicted subtype stability.
View Article and Find Full Text PDFArticle Synopsis
- This study explored how physical activity impacts motor, non-motor outcomes, and quality of life in early-stage Parkinson's disease (PD) participants.
- Researchers followed 121 PD participants using the Physical Activity Scale for the Elderly (PASE) to track changes in symptoms and quality of life over a year.
- Findings showed that higher physical activity levels at the start were linked to better motor function, cognitive performance, and reduced anxiety and apathy after one year.
Article Synopsis
- Subjective cognitive complaints (SCC) and affective symptoms are common in early Parkinson's Disease (PD), with a prevalence of 38.8% found in a study of 121 participants.
- The study used well-defined criteria to assess cognitive impairment and various scales to measure anxiety, depression, and apathy, revealing significant associations primarily in cognitively normal participants.
- The findings suggest that SCC can indicate affective disorders in those without cognitive impairment, while in cognitively impaired individuals, it may underestimate the prevalence of Mild Cognitive Impairment (PD-MCI).
Long alpha-synuclein gene promoter (Rep1) allele-carriers are linked to higher risk for Parkinson's disease (PD) and faster motor progression. Non-motor symptoms including autonomic, neuropsychiatric, and sleep disorders are common in PD. However, the relationship between Rep1 microsatellite lengths and non-motor symptoms in early PD remains to be elucidated.
View Article and Find Full Text PDFBackground: The main motor subtypes of Parkinson's disease (PD) include tremor-dominant (TD) and postural instability gait disorder (PIGD), with varying disease course that warrant the development of biomarkers capable of predicting progression according to motor subtype. The PIGD subtype is associated with a poorer prognosis, hence identification of a biomarker associated with PIGD is clinically relevant. Neurofilament light (NfL) chain is a potential biomarker of disease severity in neurological disorders including PD.
View Article and Find Full Text PDF